Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Allogene Therapeutics Inc | 22,032,040 | 22,032,040 | 0 | $46.93M | $36.35M | 22.13% | -$10.58M |
| Arvinas Inc | 3,457,815 | 3,457,815 | 0 | $27.66M | $26.24M | 15.98% | -$1.42M |
| Celcuity Inc.(CELC) | 295,652 | 295,652 | 0 | $29.55M | $23.51M | 14.31% | -$6.04M |
| Agomab Therapeutics NvADS | 75,000 | 2,151,213 | +2,076,213 | $1.04M | $22.61M | 13.77% | +$21.57M |
| Pyxis Oncology Inc | 7,032,770 | 7,032,770 | 0 | $19.48M | $20.11M | 12.25% | +$632.9K |
| Wave Life Sciences IncSHS | 0 | 1,875,000 | +1,875,000 | $0 | $7.09M | 4.32% | +$7.09M |
| Biohaven Ltd.(BHVN) | 505,645 | 505,645 | 0 | $8.00M | $6.57M | 4.00% | -$1.44M |
| Caribou Biosciences Inc | 4,690,431 | 4,690,431 | 0 | $7.88M | $5.82M | 3.54% | -$2.06M |
| Oric Pharmaceuticals Inc | 372,904 | 372,904 | 0 | $3.55M | $4.91M | 2.99% | +$1.35M |
| Cardiff Oncology Inc | 2,411,575 | 2,411,575 | 0 | $3.01M | $2.99M | 1.82% | -$24.1K |
| Spero Therapeutics Inc | 2,362,348 | 2,362,348 | 0 | $5.34M | $2.91M | 1.77% | -$2.43M |
| Zentalis Pharmaceuticals Inc | 953,834 | 953,834 | 0 | $3.85M | $2.58M | 1.57% | -$1.28M |
| Zura Bio LtdCL A | 538,841 | 538,841 | 0 | $2.88M | $2.18M | 1.33% | -$705.9K |
| Nextcure Inc | 44,347 | 44,357 | +10 | $73.0K | $225.3K | 0.14% | +$152.4K |
| Bolt Biotherapeutics Inc | 31,305 | 31,305 | 0 | $133.8K | $112.1K | 0.07% | -$21.8K |
| Ginkgo Bioworks Holdings IncCL A | 2,928 | 2,928 | 0 | $30.0K | $31.2K | 0.02% | +$1.2K |
| Senseonics Hldgs Inc | 0 | 2,171 | +2,171 | $0 | $21.7K | 0.01% | +$21.7K |
| Senseonics Holdings, Inc.(SENS) | 2,171 | 0 | -2,171 | $12.4K | $0 | — | -$12.4K |
| Wave Life Sciences, Inc.SHS(WVE) | 1,875,000 | 0 | -1,875,000 | $10.93M | $0 | — | -$10.93M |